Medicare請求データにおける血友病患者の特定方法
Stacey A Fedewa1,2, Tyler W Buckner3, Lorraine Cafuir1,2
1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
Haemophilia : the official journal of the World Federation of Hemophilia
|December 22, 2025
まとめ
Medicare請求データにおける血友病A患者(PwHA)を特定する3つの方法を比較した本研究では、診断コードのみでは症例を過大計上する可能性があり、アルゴリズムと治療データは重症でない患者や女性患者を過小評価する可能性があることがわかった。血友病研究の精度向上のためには、検証されたアルゴリズムが必要である。
関連する概念動画
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Pedigree Analysis
88.7K
Overview
88.7K
Kaplan-Meier Approach
530
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
530


